(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CONJUGADO DE FÁRMACO DE ANTICORPO COMPREENDENDO INIBIDOR DE NMT E SEU USO

Em AnáliseInvention PatentPCT · GB2023052318

Application data

Number

112025004414

Type

Invention Patent

Filing

09/08/2023

Publication

09/23/2025

PCT

GB2023052318

Progress at the INPI

Examination not yet requested
  1. Filing09/08/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 09/08/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:09/08/2026(14 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/23/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

IMPERIAL COLLEGE INNOVATIONS LIMITED

GB

MYRICX PHARMA LIMITED

GB

See this company's full portfolio

Inventors

A. B. (pessoa física)

GB

E. T. (pessoa física)

GB

R. S. (pessoa física)

GB

R. C. (pessoa física)

GB

R. B. (pessoa física)

CH

Technical data

Priority claims

EP

22194959.7 · 09/09/2022

EP

22194984.5 · 09/09/2022

GB

2305541.1 · 04/14/2023

GB

2305546.0 · 04/14/2023

Abstract

CONJUGADO DE FÁRMACO DE ANTICORPO COMPREENDENDO INIBIDOR DE NMT E SEU USO. A presente invenção refere-se a ADCs que compreendem um inibidor de NMT conjugado a um anticorpo por meio de um ligante e usos relacionados.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

09/23/2025

RPI 2855

Alteração de dados cadastrais

#1.1

03/18/2025

RPI 2828

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.